Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis
- PMID: 29394529
- DOI: 10.1111/bcpt.12975
Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis
Abstract
The respiratory disease pulmonary fibrosis (PF), which is characterized by scar formation throughout the lung, imposes a serious health burden. No effective drug without side effects has been proven to prevent this fatal lung disease. In this context, this study was undertaken to elucidate the protective effect of celastrol, a quinine methide pentacyclic triterpenoid from a Chinese medicinal plant 'thunder god vine' against bleomycin (BLM)-induced PF. We also attempted to study how the cytokine transforming growth factor-β (TGF-β) stimulates fibrosis through the induction of epithelial-mesenchymal transition (EMT) and the role of celastrol in regulating EMT. TGF-β (5 ng/ml) was administered to human alveolar epithelial adenocarcinoma A549 cells to induce fibrotic response in cells. Induction of EMT was analysed in cells through morphological analysis and expression of epithelial and mesenchymal markers by Western blotting. Bleomycin at a concentration of 3 U/Kg b.w was used to induce fibrosis in adult male rat lungs. Celastrol (5 mg/kg b.w) was given to rats twice a week after BLM administration for a period of 28 days. Western blot and immunofluorescence analyses were performed with lung tissue sample to find out the potential of celastrol in regulating EMT during the progression of fibrosis. TGF-β induces EMT in A549 cells as demonstrated by changes in epithelial cell morphology and expression of epithelial and mesenchymal marker proteins. The expressions of epithelial marker proteins E-cadherin and claudin were found to be reduced in the BLM-induced group of rats. Expression of mesenchymal markers, such as N-cadherin, snail, slug, vimentin and β-catenin, was enhanced in BLM-induced rat lungs. Celastrol reverts these cellular changes in rat lungs, and it was found that celastrol regulates EMT through the inhibition of heat shock protein 90 (HSP 90). Together, the results indicate that EMT is a crucial phenomenon for the progression of fibrosis, and celastrol provides protection against PF through the regulation of EMT.
© 2018 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).
Similar articles
-
Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.Acta Pharmacol Sin. 2016 Jun;37(6):794-804. doi: 10.1038/aps.2016.36. Epub 2016 May 2. Acta Pharmacol Sin. 2016. PMID: 27133302 Free PMC article.
-
Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.J Cell Mol Med. 2018 Sep;22(9):4354-4365. doi: 10.1111/jcmm.13725. Epub 2018 Jul 4. J Cell Mol Med. 2018. PMID: 29971947 Free PMC article.
-
Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.J Surg Res. 2015 Jul;197(1):167-75. doi: 10.1016/j.jss.2015.02.062. Epub 2015 Mar 13. J Surg Res. 2015. PMID: 25911951
-
Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis.Biochem Biophys Res Commun. 2023 Dec 17;686:149118. doi: 10.1016/j.bbrc.2023.10.050. Epub 2023 Oct 14. Biochem Biophys Res Commun. 2023. PMID: 37931361 Review.
-
Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer.Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(8):314-23. doi: 10.2183/pjab.85.314. Proc Jpn Acad Ser B Phys Biol Sci. 2009. PMID: 19838011 Free PMC article. Review.
Cited by
-
The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies.Int J Mol Sci. 2023 Dec 10;24(24):17325. doi: 10.3390/ijms242417325. Int J Mol Sci. 2023. PMID: 38139154 Free PMC article. Review.
-
Targeted liposomes for macrophages-mediated pulmonary fibrosis therapy.Drug Deliv Transl Res. 2024 Sep;14(9):2356-2369. doi: 10.1007/s13346-023-01508-3. Epub 2024 Jan 2. Drug Deliv Transl Res. 2024. PMID: 38167826
-
Celastrol inhibits migration, proliferation and transforming growth factor-β2-induced epithelial-mesenchymal transition in lens epithelial cells.Int J Ophthalmol. 2019 Oct 18;12(10):1517-1523. doi: 10.18240/ijo.2019.10.01. eCollection 2019. Int J Ophthalmol. 2019. PMID: 31637185 Free PMC article.
-
The Promising Therapeutic Potential of Celastrol for Fibrotic Diseases: A Systematic Literature Review on Its Mechanism.Cureus. 2023 Aug 28;15(8):e44269. doi: 10.7759/cureus.44269. eCollection 2023 Aug. Cureus. 2023. PMID: 37772226 Free PMC article. Review.
-
Inflammation-Associated Lung Tissue Remodeling and Fibrosis in Morphine-Dependent SIV-Infected Macaques.Am J Pathol. 2023 Apr;193(4):380-391. doi: 10.1016/j.ajpath.2022.12.016. Am J Pathol. 2023. PMID: 37003622 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials